Related Experiment Video
Updated: Aug 1, 2026

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
Published on: September 11, 2011
Absorbed dose to the fetus during bone scintigraphy
W R Hedrick1, R N DiSimone, B H Wolf
1Department of Radiology, Aultman Hospital, Canton, OH 44710.
Abstract:
The authors observed the uptake of radiopharmaceutical and calculated absorbed dose in fetuses of two patients who underwent bone scintigraphy with technetium-99m methylene diphosphonate. Dose estimates per administered activity were 17 mrad/mCi (4.6 microGy/MBq) for an 8-week-old fetus and 9.7 mrad/mCi (2.6 microGy/MBq) for an 18-week-old fetus. Neither fetus demonstrated radionuclide uptake above maternal background levels. The uterine activity showed rapid clearance, with an effective half-life of 12 minutes after reaching a maximum within 1 minute after injection. Major contribution to fetal dose comes from the presence of the radionuclide in the maternal bladder. The authors conclude that bone scintigraphy performed unknowingly in pregnant individuals presents negligible increased risk to the fetus.
Related Concept Videos
Biological Effects of Radiation
X-ray Imaging
Teratogenicity
Radiological Investigation I: X-ray and CT
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET

